These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Warfarin: an old drug but still interesting. Johnson JA Pharmacotherapy; 2008 Sep; 28(9):1081-3. PubMed ID: 18752378 [No Abstract] [Full Text] [Related]
6. Genetic variants associated with warfarin dosage in Kuwaiti population. John SE; Antony D; Eaaswarkhanth M; Hebbar P; Alkayal F; Tuomilehto J; Alsmadi O; Thanaraj TA Pharmacogenomics; 2017 Jun; 18(8):757-764. PubMed ID: 28592190 [TBL] [Abstract][Full Text] [Related]
7. Warfarin pharmacogenomics in African populations: the importance of ethnicity-based algorithms. Jallul M; Alhudiri I; Al-Eitan L; Elzagheid A Pharmacogenomics; 2022 Sep; 23(14):753-757. PubMed ID: 36004679 [TBL] [Abstract][Full Text] [Related]
8. Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes. Muyambo S; Ndadza A; Soko ND; Kruger B; Kadzirange G; Chimusa E; Masimirembwa CM; Ntsekhe M; Nhachi CFB; Dandara C OMICS; 2022 Jan; 26(1):35-50. PubMed ID: 34958284 [TBL] [Abstract][Full Text] [Related]
9. An integrative method for scoring candidate genes from association studies: application to warfarin dosing. Tatonetti NP; Dudley JT; Sagreiya H; Butte AJ; Altman RB BMC Bioinformatics; 2010 Oct; 11 Suppl 9(Suppl 9):S9. PubMed ID: 21044367 [TBL] [Abstract][Full Text] [Related]
10. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine]. Mushiroda T Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182 [TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke. Mitropoulou C; Fragoulakis V; Bozina N; Vozikis A; Supe S; Bozina T; Poljakovic Z; van Schaik RH; Patrinos GP Pharmacogenomics; 2015 Jan; 16(2):137-48. PubMed ID: 25616100 [TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada. Hafeez A; Cipriano LE; Kim RB; Zaric GS; Schwarz UI; Sarma S Pharmacoeconomics; 2024 Jan; 42(1):69-90. PubMed ID: 37596504 [TBL] [Abstract][Full Text] [Related]
13. Identifying the genotype behind the phenotype: a role model found in VKORC1 and its association with warfarin dosing. Crawford DC; Ritchie MD; Rieder MJ Pharmacogenomics; 2007 May; 8(5):487-96. PubMed ID: 17465713 [TBL] [Abstract][Full Text] [Related]
15. Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans. Hernandez W; Gamazon ER; Aquino-Michaels K; Patel S; O'Brien TJ; Harralson AF; Kittles RA; Barbour A; Tuck M; McIntosh SD; Douglas JN; Nicolae D; Cavallari LH; Perera MA Pharmacogenomics J; 2014 Jun; 14(3):223-8. PubMed ID: 24018621 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates. Al-Mahayri ZN; Khasawneh LQ; Alqasrawi MN; Altoum SM; Jamil G; Badawi S; Hamza D; George L; AlZaabi A; Ouda H; Al-Maskari F; AlKaabi J; Patrinos GP; Ali BR Hum Genomics; 2022 Sep; 16(1):42. PubMed ID: 36154845 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics: paving the path to personalized medicine. Patrinos GP; Innocenti F Pharmacogenomics; 2010 Feb; 11(2):141-6. PubMed ID: 20136354 [TBL] [Abstract][Full Text] [Related]